NEW YORK (GenomeWeb) – A team led by researchers at pharma firm Gritstone Oncology has developed a computational model for predicting cancer neoantigens.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.
In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.
A new paper says an effort to introduce gene drives into mosquitos altered the genetic makeup of the local mosquitos, but the company behind the project says the paper is flawed.
Virginia's Department of Forensic Science is offering attorneys a course on DNA testing, the Virginian-Pilot reports.
This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.